{"count":2,"index":{"built_at":"2026-07-27T05:09:59.951659+00:00","public_records":55311,"revision":"081a1ec7ff94ce2ca6ca3bee"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Risks and limits of Longevity Genetik"},"results":[{"answer":"Longevity genetics is an emerging field with clear limitations and risks. MyBody-X DNA tests analyze SNPs such as FOXO3 (rs2802292), which GWAS associate with platelet width, not directly with longevity. Other markers like NRF2 (rs6721961) relate to antioxidant response but have small effect sizes. The evidence is mostly mechanistic or from GWAS, not clinical trials. Furthermore, in Germany, the Genetic Diagnostics Act (GenDG) prohibits medical claims without physician oversight. These tests are marketed as lifestyle products, not medical diagnostics. A key risk is overinterpretation: a single SNP often explains less than 1% of lifespan variance. Interactions with environment (diet, exercise) are complex and unpredictable. Consumers should understand that longevity is polygenic and multifactorial – a single genetic test cannot provide a reliable prognosis. Limitations include lack of clinical validation, low predictive power, and legal restrictions. For medical concerns, consult a doctor.","area":"gesundheit","canonical_id":"gesundheit:canonical-356eacb90c7f20137641c73a","id":"public-6f0117ccc4d200677e6a93ee","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Risks and limits of Longevity Genetik","score":31.57621705,"snippet":"Longevity genetics is an emerging field with clear limitations and risks. MyBody-X DNA tests analyze SNPs such as FOXO3 (rs2802292), which GWAS associate with platelet width, not directly with longevity. Other markers like NRF2 (rs6721961) relate to antioxidant response but have small effect sizes. The evidence is mostly mechanistic or from GWAS, not clinical trials. Furthermore, in Germany, the Genetic Diagnostics Act (GenDG) prohibits medical claims without physician oversight. These tests are marketed as lifestyle products, not medical diagnostics. A key risk is overinterpretation: a single SNP often explains less than 1% of lifespan variance. Interactions with environment (diet, exercise","sources":[],"title":"Risks and limits of Longevity Genetik","url":"https://tikki.wiki/wissen/gesundheit/frage/public-6f0117ccc4d200677e6a93ee/risks-and-limits-of-longevity-genetik/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"APOE genetics (especially ε2, ε3, ε4 variants) is one of the most studied genetic risk factors for Alzheimer's disease. The ε4 allele significantly increases risk, but it is neither necessary nor sufficient for developing the disease. Many ε4 carriers never develop Alzheimer's, and non-carriers can still get it. Therefore, the predictive value of an APOE test is limited: it provides a probability, not a diagnosis. There is also a risk of overinterpretation and psychological distress. Associations with cardiovascular disease exist but are modest and modifiable by lifestyle. Many commercial tests promote APOE analysis with vague longevity or dietary recommendations that lack solid scientific backing. Evidence for personalized diets based on APOE is weak. Importantly, APOE testing should only be done with genetic counseling, as results can have significant psychosocial consequences (e.g., insurance discrimination, family impact). Clinical utility is debated because no established prevention strategies are specifically recommended for ε4 carriers. In summary: APOE genetics has strong evidence for Alzheimer's risk, but many limits – no diagnosis, no clear actionable steps, and ethical concerns.","area":"gesundheit","canonical_id":"gesundheit:canonical-3894127d33eac59cac35fc7c","id":"public-337cf3126f390c1095ea7c56","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Risks and limits of APOE Genetik","score":30.04000364,"snippet":"APOE genetics (especially ε2, ε3, ε4 variants) is one of the most studied genetic risk factors for Alzheimer's disease. The ε4 allele significantly increases risk, but it is neither necessary nor sufficient for developing the disease. Many ε4 carriers never develop Alzheimer's, and non-carriers can still get it. Therefore, the predictive value of an APOE test is limited: it provides a probability, not a diagnosis. There is also a risk of overinterpretation and psychological distress. Associations with cardiovascular disease exist but are modest and modifiable by lifestyle. Many commercial tests promote APOE analysis with vague longevity or dietary recommendations that lack solid scientific b","sources":[],"title":"Risks and limits of APOE Genetik","url":"https://tikki.wiki/wissen/gesundheit/frage/public-337cf3126f390c1095ea7c56/risks-and-limits-of-apoe-genetik/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}